Journal/Magazine Articles

Permanent URI for this collectionhttp://repository.kln.ac.lk/handle/123456789/13

This collection contains original research articles, review articles and case reports published in local and international peer reviewed journals by the staff members of the Faculty of Medicine

Browse

Search Results

Now showing 1 - 4 of 4
  • Item
    High levels of serum angiopoietin 2 and angiopoietin 2/1 ratio at the critical stage of Dengue Hemorrhagic Fever in patients and association with clinical and biochemical parameters
    (American Society for Microbiology., 2020) Mapalagamage, M.; Handunnetti, S.M.; Wickremasinghe, A.R.; Premawansa, G.; Thillainathan, S.; Fernando, T.; Kanapathippillai, K.; de Silva, A.D.; Premawansa, S.
    ABSTRACT:Longitudinal changes of serum angiopoietin 1 (Ang-1) and angiopoietin 2 (Ang-2) associated with endothelial stability in dengue patients with different disease stages were studied. Serum Ang-1 and Ang-2 levels were measured in confirmed dengue fever (DF) patients on admission (DFA, n = 40) and discharge (DFD, n = 20); in dengue hemorrhagic fever (DHF) patients on admission (DHFA, n = 40), at critical stage (DHFC, n = 36), and on discharge (DHFD, n = 20); and in healthy controls (HC, n = 25). DHFC had the highest serum Ang-2 and lowest Ang-1 levels compared to DFA, DHFA, and HC (P < 0.050). The ratio of serum Ang-2/Ang-1 in DHFC was the highest among all study categories tested (P < 0.001). Significant positive correlations were observed between serum Ang-1 and platelet count in DHFA (Pearson r = 0.653, P < 0.001) and between Ang-1 and pulse pressure in DHFC (r = 0.636, P = 0.001). Using a cutoff value of 1.01 for the Ang-2/Ang-1 ratio for DHFC, a sensitivity of 83.2% and a specificity of 81.2% discerning DF from DHF were obtained. Therefore, serum Ang-2/Ang-1 could be used as a biomarker for endothelial dysfunction in severe dengue at the critical stage. KEYWORDS: angiopoietin; biomarker; dengue fever; dengue hemorrhagic fever; endothelial dysfunction.
  • Item
    Serum nitrite levels in Sri Lankan patients with leptospirosis
    (Elsevier, Singapore, 2012) Gunaratna, R.I.; Handunnetti, S.M.; Bulathsinghalage, M.R.C.; Somaratne, P.; Jayanaga, A.; de Silva, H.J.; Rajapakse, S.
    OBJECTIVE: To determine whether blood nitrite levels are elevated in patients with leptospirosis.METHODS: Male patients fulfilling clinical and epidemiological criteria for a diagnosis of leptospirosis were recruited. Those with MAT titre of ≤400 together with those seroconverting to a titer of ≤200 were included in the analysis. Serum nitrite levels were measured in these patients and age, sex matched healthy controls. RESULTS: Patients from 3 hospitals (n=75) were screened during a 3 month period from 28th June to 3rd September 2009, of whom 20 were eligible for the study. Serum nitrite levels were found to be significantly higher in patients with acute leptospirosis [n=20, (0.359±0.229)μ M] compared to controls [(n=13,(0.216±0.051)μ M](P=0.014). A significant correlation was also observed between the MAT titre and the day of illness (r = 0.547; P<0.0001). CONCLUSIONS: Serum nitrite levels are higher in patients with acute leptospirosis compared to age and sex matched controls. No correlation could be assessed with severity of illness, as sample size was inadequate to determine this
  • Item
    ABO-blood-group types and protection against severe, Plasmodium falciparum malaria
    (Academic Press, 2005) Pathirana, S.L.; Alles, H.K.; Bandara, S.; Phone-Kyaw, M.; Perera, M.K.; Wickremasinghe, A.R.; Mendis, K.N.; Handunnetti, S.M.
  • Item
    A Double antibody sandwich ELISA for the diagnosis of vivax malaria: a tool for further research
    (University of Colombo, 2000) Seneviratna, G.D.C.N.; Manamperi, A.A.P.S.; Kapilananda, G.M.G.; Longacre, S.; Handunnetti, S.M.; Udagama-Randeniya, P.V.
    A diagnostic assay for Plasmodium vivax based on a double antibody sandwich enzyme-linked immunosorbent assay (DAS ELISA) was established to detect the merozoite surface protein 1 (PvMSP1) in wild isolates. This assay was based on the recombinant protein p19, a C-terminal processing product of PvMSP1. Of the two anti-P. vivax monoclonal antibodies (MAbs) selected, A21 was used as the capture antibody while horse radish peroxidase labelled A8 served as the probing second antibody. Optimized conditions established for p19 based DAS ELISA with the exception of a lower concentration of Tween-20 in buffers were suitable to screen lysed whole blood of malaria patients. This assay had a specificity of 100 percent for P. vivax and all the isolates of P. falciparum tested negative. Of the P. vivax-infected blood samples, only those containing both compact and schizont stages were diagnosed positive. The rest of the isolates tested negative either due to stage specificity of this assay or to the antigenic diversity of PvMSP1 in wild isolates. This test demonstrated a sensitivity of 27.58 percent and an accuracy of 63.15 percent. The positive and negative predicted values of this ELISA were 100 percent and 57.14 percent, respectively. Therefore, the P. vivax specific DAS ELISA developed and tested in the present study is not sufficiently sensitive to be used as a diagnostic tool for vivax malaria. Nevertheless, a baseline was established for development of diagnostic ELISA for future use with a more appropriate antigen.